These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 21040087)

  • 21. Osteonecrosis of jaws after bisphosphonates: an internet resource on the web for dentist.
    Hon NC
    Singapore Dent J; 2007 Dec; 29(1):19-21. PubMed ID: 18472526
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bisphosphonates and oral health: primer and an update for the practicing surgeon.
    Assael LA
    Oral Maxillofac Surg Clin North Am; 2011 Aug; 23(3):443-53. PubMed ID: 21798442
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nonexposed variant of bisphosphonate-associated osteonecrosis of the jaw: a case series.
    Fedele S; Porter SR; D'Aiuto F; Aljohani S; Vescovi P; Manfredi M; Arduino PG; Broccoletti R; Musciotto A; Di Fede O; Lazarovici TS; Campisi G; Yarom N
    Am J Med; 2010 Nov; 123(11):1060-4. PubMed ID: 20851366
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dental management of patients with a history of bisphosphonate therapy: clinical dilemma.
    Migliorati CA; Hsu CJ; Chopra S; Kaltman SS
    J Calif Dent Assoc; 2008 Oct; 36(10):769-74. PubMed ID: 19044097
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bisphosphonate therapy and dental treatment.
    Phillips G
    J Mich Dent Assoc; 2009 Aug; 91(8):40, 42-5. PubMed ID: 19722373
    [No Abstract]   [Full Text] [Related]  

  • 26. Beyond bisphosphonates: thrombophilia, hypofibrinolysis, and jaw osteonecrosis.
    McMahon RE; Bouquot JE; Glueck CJ; Griep J
    J Oral Maxillofac Surg; 2006 Nov; 64(11):1704-5. PubMed ID: 17052602
    [No Abstract]   [Full Text] [Related]  

  • 27. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaw - 2009 update.
    Ruggiero SL; Dodson TB; Assael LA; Landesberg R; Marx RE; Mehrotra B;
    Aust Endod J; 2009 Dec; 35(3):119-30. PubMed ID: 19961450
    [No Abstract]   [Full Text] [Related]  

  • 28. Jaw osteonecrosis related to bisphosphonates: a new concern for dentistry.
    Geist RY; Geist JR; Aksu M
    J Mich Dent Assoc; 2005 Nov; 87(11):40-2. PubMed ID: 16372547
    [No Abstract]   [Full Text] [Related]  

  • 29. Oral bisphosphonates as a cause of bisphosphonate-related osteonecrosis of the jaws: clinical findings, assessment of risks, and preventive strategies.
    Assael LA
    J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):35-43. PubMed ID: 19371813
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Denosumab, an Alternative to Bisphosphonates but also Associated with Osteonecrosis of the Jaw--What is the Risk?
    Sidhu HK
    Dent Update; 2015 Jun; 42(5):436-8, 440. PubMed ID: 26964445
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A physician discusses the dental impact of oral bisphosphonates.
    Roudebush CP
    J Indiana Dent Assoc; 2006-2007 Winter; 85(4):4-5. PubMed ID: 17489111
    [No Abstract]   [Full Text] [Related]  

  • 32. Bisphosphonates, as a new cause of drug-induced jaw osteonecrosis: an update.
    Jimenez-Soriano Y; Bagan JV
    Med Oral Patol Oral Cir Bucal; 2005 Jul; 10 Suppl 2():E88-91. PubMed ID: 15995577
    [No Abstract]   [Full Text] [Related]  

  • 33. [Bisphosphonates (BP) and osteonecrosis of the jaws; should administration of BP be discontinued at the early phase?].
    Urade M
    Clin Calcium; 2010 Nov; 20(11):1740-3. PubMed ID: 21066911
    [No Abstract]   [Full Text] [Related]  

  • 34. Osteonecrosis of the jaw related to the use of bisphosphonates.
    Van den Wyngaert T; Huizing MT; Vermorken JB
    Curr Opin Oncol; 2007 Jul; 19(4):315-22. PubMed ID: 17545793
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of patients on bisphosphonates and prevention of bisphosphonate-related osteonecrosis of the jaw.
    Chu V; ;
    Hawaii Dent J; 2008; 39(5):9-12; quiz 17. PubMed ID: 19189512
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Osteonecrosis of the jaw & osteoporosis therapy.
    Kessenich CR
    Nurse Pract; 2010 Jul; 35(7):51-3. PubMed ID: 20555246
    [No Abstract]   [Full Text] [Related]  

  • 37. The incidence of jaw osteonecrosis in multiple myeloma patients treated with bisphosphonates.
    Kraj M; Pogłód R; Maj S; Owczarska K
    Acta Pol Pharm; 2006; 63(5):450-2. PubMed ID: 17357613
    [No Abstract]   [Full Text] [Related]  

  • 38. Bisphosphonate-related osteonecrosis of the jaw: background and guidelines for diagnosis, staging and management.
    Ruggiero SL; Fantasia J; Carlson E
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Oct; 102(4):433-41. PubMed ID: 16997108
    [No Abstract]   [Full Text] [Related]  

  • 39. Bisphosphonates and oral health.
    Ritter AV; Padilla R
    J Esthet Restor Dent; 2008; 20(1):74-5. PubMed ID: 18237344
    [No Abstract]   [Full Text] [Related]  

  • 40. Bisphosphonates, osteonecrosis of the jaw, and dental treatment recommendations.
    Radfar L; Masood F
    J Okla Dent Assoc; 2008; 99(7):28-9. PubMed ID: 18595621
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.